Grail, a biotechnical company based out of California and with locations in Washington, DC, Research Triangle Park NC, and London, UK, has developed new multi-cancer early detection (MCED) test that checks a person’s blood for cancer. The company has conducted many clinical studies with over 380,000 participants.